Thema: US57777K1060
MXCT, US57777K1060
tesla-6537378_1920.jpg - Foto: THN
MaxCyte stock quote holds at EUR 1.53 late on October 29
MaxCyte stock was unchanged in the displayed late snapshot. The quote showed a bid-ask spread for investors tracking the US biotech company.
ad-hoc-news.de, heute 02:15 Uhr
MXCT, US57777K1060
MaxCyte consensus sets USD 6.00 target for MaxCyte stock ...
MaxCyte guides to USD 34.00 million for fiscal 2026. MaxCyte stock costs EUR 1.18 on October 20, 2026 at USD 136.7 million value.
ad-hoc-news.de, 20.10.26 19:51 Uhr
MXCT, US57777K1060
MaxCyte stock has November 10, 2026 earnings date
MaxCyte's trailing P/E was minus 3.89 on October 16, 2026. MaxCyte stock closed at USD 1.30 on October 16, 2026, unchanged versus the prior close.
ad-hoc-news.de, 17.10.26 21:05 Uhr
MXCT, US57777K1060
November 10, 2026 results are next for MaxCyte stock
Third-quarter core revenue reached USD 8.10 million, up 26.00 percent. MaxCyte stock costs EUR 1.15 on October 15, 2026, up 3.20 percent on Nasdaq.
ad-hoc-news.de, 15.10.26 19:26 Uhr
MXCT, US57777K1060
MaxCyte stock fell 3.67 percent on October 7
MaxCyte stock posted USD 7.271 million in second-quarter revenue, down 15 percent year over year. Fiscal 2026 guidance stayed at USD 30 million to USD 32 million.
ad-hoc-news.de, 08.10.26 05:49 Uhr
MXCT, US57777K1060
MaxCyte stock gained 0.9 percent as revenue fell 15 percent ...
MaxCyte stock was last at USD 1.08 on October 6, 2026, while six analysts set a USD 4.108 average target. Second-quarter revenue reached USD 7.3 million.
ad-hoc-news.de, 07.10.26 03:49 Uhr
MXCT, US57777K1060
MaxCyte stock falls as revenue and market value remain under ...
MaxCyte stock traded at USD 1.17 on September 22, 2026, down 2.5 percent with a USD 120.24 million market value. Revenue was USD 33.03 million.
ad-hoc-news.de, 23.09.26 10:27 Uhr
